Julie Rubinstein - Net Worth and Insider Trading
Julie Rubinstein Net Worth
The estimated net worth of Julie Rubinstein is at least $5 Million dollars as of 2025-05-11. Julie Rubinstein is the President and COO of Adaptive Biotechnologies Corp and owns about 588,249 shares of Adaptive Biotechnologies Corp (ADPT) stock worth over $5 Million. Details can be seen in Julie Rubinstein's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Julie Rubinstein has not made any transactions after 2025-03-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Julie Rubinstein
Julie Rubinstein Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Julie Rubinstein owns 1 companies in total, including Adaptive Biotechnologies Corp (ADPT) .
Click here to see the complete history of Julie Rubinstein’s form 4 insider trades.
Insider Ownership Summary of Julie Rubinstein
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ADPT | Adaptive Biotechnologies Corp | 2025-03-05 | President |
Julie Rubinstein Latest Holdings Summary
Julie Rubinstein currently owns a total of 1 stock. Julie Rubinstein owns 588,249 shares of Adaptive Biotechnologies Corp (ADPT) as of March 5, 2025, with a value of $5 Million.
Latest Holdings of Julie Rubinstein
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ADPT | Adaptive Biotechnologies Corp | 2025-03-05 | 588,249 | 9.03 | 5,311,888 |
Holding Weightings of Julie Rubinstein
Julie Rubinstein Form 4 Trading Tracker
According to the SEC Form 4 filings, Julie Rubinstein has made a total of 35 transactions in Adaptive Biotechnologies Corp (ADPT) over the past 5 years, including 0 buys and 35 sells. The most-recent trade in Adaptive Biotechnologies Corp is the sale of 59,505 shares on March 5, 2025, which brought Julie Rubinstein around $415,345.
Insider Trading History of Julie Rubinstein
- 1
Julie Rubinstein Trading Performance
Julie Rubinstein Ownership Network
Ownership Network List of Julie Rubinstein
Ownership Network Relation of Julie Rubinstein
Julie Rubinstein's Compensation Overview
| Company | Year | Salary($) | Bonus($) | Stock Awards($) | Option Awards($) | Equity Awards($) | Non-Equity Incentive Plan($) | All Other Compensation($) | Change in Pension and Deferred Comp($) | Total($) |
|---|---|---|---|---|---|---|---|---|---|---|
| Adaptive Biotechnologies Corp | 2023 | 530,450 | N/A | 1,125,002 | 1,124,997 | N/A | 185,658 | 4,932 | N/A | 2,971,039 |
 | | | | | | | | | | |
| | | | | | | | | | |
Julie Rubinstein Owned Company Details
What does Adaptive Biotechnologies Corp do?
Who are the key executives at Adaptive Biotechnologies Corp?
Julie Rubinstein is the President of Adaptive Biotechnologies Corp. Other key executives at Adaptive Biotechnologies Corp include Chief Scientific Officer Harlan S Robins , director & CEO and Chairman Chad M Robins , and Principal Accounting Officer Kyle Piskel .
Adaptive Biotechnologies Corp (ADPT) Insider Trades Summary
Over the past 18 months, Julie Rubinstein made 2 insider transaction in Adaptive Biotechnologies Corp (ADPT) with a net sale of 98,575. Other recent insider transactions involving Adaptive Biotechnologies Corp (ADPT) include a net sale of 1,023,797 shares made by Chad M Robins , a net sale of 18,554 shares made by Kyle Piskel , and a net sale of 166,766 shares made by Harlan S Robins .
In summary, during the past 3 months, insiders sold 1,418,233 shares of Adaptive Biotechnologies Corp (ADPT) in total and bought 0 shares, with a net sale of 1,418,233 shares. During the past 18 months, 1,627,050 shares of Adaptive Biotechnologies Corp (ADPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,627,050 shares.
Adaptive Biotechnologies Corp (ADPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adaptive Biotechnologies Corp Insider Transactions
Julie Rubinstein Mailing Address
Above is the net worth, insider trading, and ownership report for Julie Rubinstein. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Julie Rubinstein's mailing address is: Seattle Wa 98102.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
